Softgel Capsules Market Size, Share, Growth, and Industry Analysis, By Type (Gelatin Type, Non-animal Type), By Application (Cannabis Extracts & CBD Industry, Health Supplements, Pharmaceutical, Others), Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

SOFTGEL CAPSULES MARKET OVERVIEW

The global Softgel Capsules Market size estimated at USD 13.11 billion in 2026 and is projected to reach USD 25.82 billion by 2035, growing at a CAGR of 7.83% from 2026 to 2035.

The Softgel Capsules Market continues to expand due to increasing pharmaceutical consumption, dietary supplement adoption, and advanced encapsulation technologies. Softgel capsules represent a major dosage form because of improved bioavailability, controlled release capability, and patient convenience. More than 65% of oral nutraceutical products launched globally in 2025 included softgel delivery formats. Global pharmaceutical manufacturing exceeded 1.9 trillion dosage units during 2025, with encapsulated formulations contributing a substantial portion. Softgel capsule filling accuracy reached 99% in automated production systems, supporting high-volume manufacturing. Vegetarian softgel adoption reached 24% of total softgel production volume during 2025 due to demand for non-animal alternatives.

The United States remains a leading contributor to the Softgel Capsules Market because of pharmaceutical innovation, supplement consumption, and manufacturing capacity. More than 77% of adults in the United States reported dietary supplement usage in 2025, with softgel products among the most consumed formats. Pharmaceutical solid oral dosage production exceeded 450 billion units annually. Approximately 58% of omega-based nutritional products sold in the country were delivered in softgel format. Domestic pharmaceutical facilities operated with average utilization above 82%, while encapsulation technology investment increased by 14% during 2025. Non-gelatin capsule adoption reached 19% of total U.S. softgel output.

KEY FINDINGS

LATEST TRENDS

Softgel capsules continue evolving through formulation innovation, clean-label preferences, and precision manufacturing. During 2025, more than 41% of newly introduced dietary supplement products adopted encapsulated delivery systems. Enhanced absorption technologies improved active ingredient utilization by 27% across selected formulations. Liquid-filled delivery represented 53% of premium nutritional products introduced globally. Vegetarian and non-animal softgel technologies gained momentum, reaching 24% of total production volume.

Modified starch and carrageenan-based shells increased manufacturing usage by 17%. Encapsulation line automation improved operational efficiency by 21% and reduced production defects by 13%. Pharmaceutical applications maintained strong adoption because softgel formats delivered improved dissolution performance. Clinical observations showed liquid encapsulated formulations achieving absorption improvements of 18% compared with selected conventional tablet forms.

MARKET DYNAMICS

Driver

Rising demand for pharmaceuticals and health supplements.

Increasing pharmaceutical and supplement consumption remains the strongest growth factor in the Softgel Capsules Market. Global supplement penetration exceeded 62% among adult consumers during 2025. Softgel formats became preferred because swallowing comfort improved user acceptance by 33% compared with traditional compressed tablets. Pharmaceutical manufacturers reported encapsulated dosage expansion across 49% of newly developed oral products. Omega oils, vitamins, botanical extracts, and lipid-soluble ingredients demonstrated higher delivery efficiency through softgel systems.

Restraint

Complex manufacturing and shell sensitivity.

Softgel production requires controlled temperature, humidity, and ingredient compatibility, creating operational limitations. Manufacturing environments maintained humidity levels below 35% for quality consistency. Shell deformation affected approximately 9% of rejected batches in sensitive conditions. Gelatin dependency continued to challenge manufacturers because animal-origin raw materials represented 76% of conventional production inputs. Transportation sensitivity increased logistics requirements by 12%. Stability testing periods extended product launch timelines by an average of 14%, creating delays in commercialization and inventory planning.

Growth in personalized medicines and plant-based formulations

Opportunity

Personalized nutrition and customized pharmaceutical delivery are opening new opportunities in the Softgel Capsules Market. Consumer preference for customized dosage solutions reached 31% in 2025. Plant-derived shell technologies accounted for 24% of production and expanded rapidly across nutraceutical launches.

Personalized supplement subscriptions increased by 18%, encouraging smaller batch encapsulation systems. Functional ingredients requiring lipid protection recorded adoption growth of 22%. Precision encapsulation equipment reduced material losses by 11% and supported flexible manufacturing environments with higher formulation diversity.

Rising operational costs and technical compliance requirements

Challenge

Manufacturers continue facing challenges linked to compliance standards, process control, and raw material volatility. Production equipment maintenance increased operating expenses by 9%, while validation procedures extended development cycles by 13%. More than 44% of facilities implemented additional environmental monitoring systems.

Regulatory documentation requirements increased quality assurance workloads by 16%. Energy-intensive drying processes contributed significantly to operating complexity. Product recall prevention programs increased inspection frequency by 19%, requiring continuous investments in process optimization and workforce training.

•   
•   
  

  Download Free Sample to learn more about this report

    

SOFTGEL CAPSULES MARKET SEGMENTATION

By Type

• Gelatin Type: Gelatin softgel capsules dominated with approximately 76% market share during 2025. Their popularity is driven by high elasticity, rapid dissolution, and production efficiency. More than 81% of prescription-compatible softgel formulations continued using gelatin shells. Production line speeds exceeded 300,000 capsules per hour in large facilities. Gelatin capsules demonstrated moisture retention efficiency above 92% and achieved stable encapsulation performance for oil-based ingredients. Pharmaceutical and supplement manufacturers preferred gelatin because formulation validation periods were shorter by 14% compared with newer alternatives.

• Non-animal Type: Non-animal softgel capsules represented approximately 24% market share and experienced stronger adoption among health-conscious consumers. Plant-derived formulations increased production utilization by 17% during 2025. Carrageenan and modified starch technologies accounted for more than 63% of non-animal shell development projects. Shelf stability improved by 12% through upgraded moisture barriers. Vegan-certified product launches increased by 21%, while premium supplement manufacturers reported demand expansion exceeding 18%.

By Application

• Cannabis Extracts & CBD Industry: Cannabis extracts and CBD applications contributed approximately 12% of total market demand. Softgel delivery improved dosage consistency and absorption efficiency by 19%. Encapsulated cannabinoid products achieved content uniformity above 97%. Consumer preference for discreet dosage forms increased product penetration by 15%. Controlled-release technologies enhanced formulation stability and reduced oxidation exposure by 11%. Manufacturers expanded encapsulated cannabinoid portfolios to address medical and wellness consumption trends.

• Health Supplements: Health supplements accounted for approximately 34% of market utilization. Vitamins, omega oils, and mineral formulations remained dominant categories. Consumer supplement participation exceeded 62% globally. Softgel formats improved user compliance by 29% due to easier swallowing characteristics. Omega-related softgel products represented 38% of supplement capsule volume. Encapsulation technologies reduced ingredient degradation by 16% and improved product shelf consistency.

• Pharmaceutical: Pharmaceutical applications held approximately 46% market share. Oral liquid formulations expanded because softgel capsules improved active ingredient absorption by 18%. More than 58% of lipid-based pharmaceutical products selected softgel encapsulation. Manufacturing consistency exceeded 99% in automated lines. Clinical preference increased due to controlled release and reduced gastrointestinal irritation. Pharmaceutical-grade quality systems supported higher adoption across regulated therapeutic categories.

• Others: Other applications represented approximately 8% of market utilization, including veterinary products, specialty nutrition, and cosmetic formulations. Veterinary supplement encapsulation expanded by 13% in 2025. Beauty-from-within products recorded 21% product launch growth. Functional ingredient delivery improved formulation protection by 14%. Specialty industrial applications continued adopting softgel technologies because of dosage precision and product differentiation.

•   
•   
  Download Free Sample to learn more about this report

    

SOFTGEL CAPSULES MARKET REGIONAL OUTLOOK

• North America

North America held approximately 36% of the Softgel Capsules Market and remained the leading regional producer and consumer. The region operated more than 420 major pharmaceutical and nutraceutical manufacturing facilities using encapsulation technologies. Dietary supplement penetration exceeded 77% among adults, creating strong demand for softgel dosage forms. Softgel products represented approximately 58% of omega-based supplement consumption across the region.

The United States accounted for the majority of regional production capacity and maintained utilization rates above 82% in pharmaceutical facilities. Automated encapsulation systems improved production efficiency by 21% and reduced product variation by 12%. More than 46% of newly commercialized lipid-based formulations entered the market using softgel delivery systems.

• Europe

Europe represented approximately 29% of the Softgel Capsules Market due to mature pharmaceutical infrastructure and sustained nutraceutical demand. More than 310 pharmaceutical facilities across Europe maintained dedicated encapsulation capabilities. Consumer supplement usage exceeded 56% across major European economies.

Germany, Italy, France, and the United Kingdom remained major manufacturing centers. Pharmaceutical applications accounted for approximately 49% of regional softgel consumption. Advanced formulation technologies improved dissolution efficiency by 16%, while manufacturing defect rates declined by 11%. European manufacturers accelerated transition toward plant-based encapsulation systems, resulting in non-animal capsules reaching 28% of regional production.

• Asia-Pacific

Asia-Pacific accounted for approximately 27% of the Softgel Capsules Market and recorded strong industrial expansion supported by pharmaceutical manufacturing growth and increasing healthcare accessibility. Regional encapsulation production capacity increased by 18% during 2025. More than 680 manufacturing facilities operated across major economies.

China maintained leadership in production volume due to large-scale pharmaceutical and nutraceutical manufacturing infrastructure. India expanded encapsulation output through contract manufacturing and domestic healthcare demand. Japan continued focusing on precision dosage systems and premium supplement categories.

• Middle East & Africa

Middle East & Africa represented approximately 8% of the Softgel Capsules Market and continued expanding through healthcare modernization and pharmaceutical localization efforts. Regional pharmaceutical consumption increased steadily, with encapsulated dosage products gaining stronger acceptance among consumers.

Local production initiatives supported installation of encapsulation equipment across several industrial zones. Manufacturing productivity improved by 12% due to process modernization. Import dependency remained significant but declined by 8% as domestic capabilities improved. Health supplements contributed approximately 35% of regional softgel demand, supported by preventive healthcare trends.

LIST OF TOP SOFTGEL CAPSULES COMPANIES

• Strides Pharma Science Limited
• Captek Softgel International Inc.
• Amway
• Soft Gel Technologies, Inc.
• Capsugel
• Sirio Pharma Co. Ltd.
• EuroCaps Ltd.
• Catalent, Inc.
• Weihai Baihe Biology Technological Co. Ltd.
• Patheon
• International Vitamin Corporation

List Of Top 2 Companies Market Share

• Catalent, Inc. – Estimated market share approximately 14%, supported by large-scale encapsulation infrastructure, pharmaceutical partnerships, and global production capabilities.
• Capsugel – Estimated market share approximately 11%, supported by diversified dosage technologies, broad pharmaceutical integration, and extensive manufacturing operations.

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment activity in the Softgel Capsules Market accelerated due to rising demand for pharmaceutical and nutritional delivery systems. Manufacturing facilities increased encapsulation equipment expenditure by 16% during 2025 to improve throughput and reduce defect rates. Automated filling technologies improved production efficiency by 21% and lowered operational losses by 10%. Investors focused on facilities capable of producing both gelatin and non-animal capsules to address changing consumer preferences. Plant-based softgel production expanded to 24% of total output, creating opportunities in specialized manufacturing.

Pharmaceutical outsourcing supported approximately 33% of industry production volume, encouraging capacity expansion. Emerging economies increased pharmaceutical infrastructure investments and supported additional encapsulation lines. Production flexibility improved by 14% through modular equipment systems. Demand for liquid-fill formulations increased by 18%, encouraging technological upgrades. Personalized supplement platforms expanded by 18%, creating opportunities for small-batch encapsulation and premium dosage solutions.

NEW PRODUCT DEVELOPMENT

Product development in the Softgel Capsules Market increasingly focuses on absorption enhancement, clean-label formulations, and advanced shell technologies. During 2025, more than 41% of newly introduced supplement products adopted encapsulated delivery formats. Manufacturers introduced moisture-resistant shells that improved stability by 15% and reduced oxidation exposure by 11%. Encapsulation innovations enabled active ingredient protection exceeding 92%. Liquid suspension technologies improved dissolution performance by 18%.

Vegetarian and non-animal softgel launches increased by 21%, supported by demand for plant-derived ingredients. Modified starch formulations improved shell durability by 13%. Multi-layer encapsulation solutions expanded dosage flexibility and enhanced ingredient separation performance. Pharmaceutical innovation emphasized controlled-release softgel systems capable of improving ingredient availability by 17%. Customization technologies enabled production of multiple capsule sizes and improved visual differentiation.

FIVE RECENT DEVELOPMENTS (2023-2025)

• Catalent, Inc. expanded softgel manufacturing capacity through production optimization initiatives during 2023, improving encapsulation throughput by 15% and increasing automated inspection coverage above 95% across selected facilities.
• Sirio Pharma Co. Ltd. accelerated plant-based softgel development in 2024, increasing non-animal encapsulation output by 18% and expanding customized nutraceutical softgel offerings across multiple international markets.
• Patheon introduced upgraded pharmaceutical encapsulation process controls during 2024, reducing batch deviation levels by 11% and improving operational utilization above 84% in selected production environments.
• Captek Softgel International Inc. implemented advanced formulation and encapsulation technologies in 2025 that improved ingredient protection by 14% and increased production efficiency by 16%.
• International Vitamin Corporation expanded supplement-oriented softgel manufacturing capabilities during 2025, increasing encapsulated product portfolio volume by 19% and improving production line precision above 98%.

SOFTGEL CAPSULES MARKET REPORT COVERAGE

The Softgel Capsules Market report provides comprehensive assessment of manufacturing developments, technology adoption, product segmentation, regional performance, competitive structure, and investment activities across pharmaceutical and nutraceutical sectors. The report evaluates production capacity, encapsulation technologies, shell material evolution, and application trends using verified industry indicators and measurable market statistics. Coverage includes analysis of gelatin and non-animal softgel categories, where gelatin maintained approximately 76% market participation and non-animal products represented 24%.

Application assessment covers pharmaceuticals with 46% share, health supplements with 34%, cannabis extracts and CBD with 12%, and other applications with 8%. Regional assessment covers North America with 36% share, Europe with 29%, Asia-Pacific with 27%, and Middle East & Africa with 8%. Manufacturing evaluation includes automated encapsulation adoption exceeding 44%, production accuracy above 99%, and operational productivity improvements reaching 21%.